Search research articles
Contact Us
Filters
Showing results (211-220 of 222) with videos related to
Page
of 23
Sort By:
Renal Failure
|
January 24, 2024
Left ventricular remodeling and its association with mineral and bone disorder in kidney transplant recipients
Li Sun, Dongliang Zhang, Jiawen Liu, et al.
Oncotarget
|
September 30, 2016
Perioperative treatments for resected upper tract urothelial carcinoma: a network meta-analysis
Xiao Yang, Peng Li, Xiaheng Deng, et al.
Oncotarget
|
October 4, 2017
Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients
Gong Cheng, Shangqian Wang, Xiao Li, et al.
Plos One
|
November 20, 2013
Association of the glutathione s-transferase m1, t1 polymorphisms with cancer: evidence from a meta-analysis
Jianzheng Fang, Shangqian Wang, Shengli Zhang, et al.
Oncotarget
|
November 3, 2016
Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma
Yiyang Liu, Jian Qian, Xiao Li, et al.
Proteomics
|
November 22, 2013
Proteomic characteristics of human sperm cryopreservation
Shangqian Wang, Wei Wang, Yang Xu, et al.
Urology
|
March 19, 2019
Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
Zhangqun Ye, Jian Huang, Liqun Zhou, et al.
Cancer Biology & Medicine
|
February 6, 2024
Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer
Nanhui Chen, Zengjun Wang, Ming Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2022
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
Xinan Sheng, Dingwei Ye, Aiping Zhou, et al.
The Lancet. Oncology
|
September 4, 2025
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
Aiping Zhou, Pengfei Shen, Juan Li, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 222) with videos related to
Sort By:
Page
of 23
Renal Failure
|
January 24, 2024
Left ventricular remodeling and its association with mineral and bone disorder in kidney transplant recipients
Li Sun, Dongliang Zhang, Jiawen Liu, et al.
Oncotarget
|
September 30, 2016
Perioperative treatments for resected upper tract urothelial carcinoma: a network meta-analysis
Xiao Yang, Peng Li, Xiaheng Deng, et al.
Oncotarget
|
October 4, 2017
Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients
Gong Cheng, Shangqian Wang, Xiao Li, et al.
Plos One
|
November 20, 2013
Association of the glutathione s-transferase m1, t1 polymorphisms with cancer: evidence from a meta-analysis
Jianzheng Fang, Shangqian Wang, Shengli Zhang, et al.
Oncotarget
|
November 3, 2016
Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma
Yiyang Liu, Jian Qian, Xiao Li, et al.
Proteomics
|
November 22, 2013
Proteomic characteristics of human sperm cryopreservation
Shangqian Wang, Wei Wang, Yang Xu, et al.
Urology
|
March 19, 2019
Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
Zhangqun Ye, Jian Huang, Liqun Zhou, et al.
Cancer Biology & Medicine
|
February 6, 2024
Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer
Nanhui Chen, Zengjun Wang, Ming Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2022
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
Xinan Sheng, Dingwei Ye, Aiping Zhou, et al.
The Lancet. Oncology
|
September 4, 2025
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
Aiping Zhou, Pengfei Shen, Juan Li, et al.
Page
of 23